pertuzumab,letrozole,trastuzumab
novartis,roche
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'breast', 'perelisa', 'letrozole', 'pertuzumab']
#esmo2022: new validation data of #her2dx in the perelisa trial: it predicts the response of #trastuzumab, #pertuzumab and #letrozole administered before surgery in patients with #her2+ hr+ #breastcancer. read the press release here: 
We want to change how biomarkers are routinely used in oncology. #HER2DX